Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.61 |
| ▸ | ACP3 | P15309 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | CASR | P41180 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30763462 | 1.00 | SIGMAR1 (0.61) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| SCHEMBL3749295 | 1.00 | SIGMAR1 (0.61) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| SCHEMBL8437895 | 1.00 | SIGMAR1 (0.61) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| SCHEMBL1200137 | 1.00 | SIGMAR1 (0.61) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| Hydrochloric Acid SCHEMBL2469805 | 0.97 | SIGMAR1 (0.59) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| Hydrochloric Acid SCHEMBL607712 | 0.97 | SIGMAR1 (0.59) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| Hydrochloric Acid SCHEMBL3078151 | 0.97 | SIGMAR1 (0.59) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| SCHEMBL8433113 | 0.89 | SIGMAR1 (0.57) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| SCHEMBL278474 | 0.89 | SIGMAR1 (0.57) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 | |
| SCHEMBL8433689 | 0.89 | SIGMAR1 (0.57) | SIGMAR1ACP3CYP3A4CYP2D6CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 613 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040461-A | Spirobarbitudes compound, preparation method and application | 北京工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120040462-A | Spiropyrazinone compound, preparation method and application | 北京工业大学 | 2025-05-27 | — | — | CN | claimed |
| WO-2025089950-A1 | PROCESS FOR REMOVING CO2 FROM GAS | CARBONORO TECHNOLOGY B.V. (NL) | 2025-05-01 | — | — | WO | claimed |
| CN-111193069-B | Electrolyte for electrochemical device, method for preparing the same, and electrochemical device | 三星电子株式会社 | 2024-11-01 | — | — | CN | claimed |
| EP-4274878-A1 | BASIC ASHLESS ADDITIVES AND LUBRICATING COMPOSITIONS CONTAINING SAME | The Lubrizol Corporation (US) | 2023-11-15 | — | — | EP | claimed |
| CN-111032047-B | Method for producing optically active compound | 多特疗法-1公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116813643-A | Chiral oxo-bridged oxazolyl heterocyclic compound and preparation method thereof | 北京工业大学 | 2023-09-29 | — | — | CN | claimed |
| US-11746180-B2 | Catalysts for polyurethane foam polyol premixes containing halogenated olefin blowing agents | HONEYWELL INTERNATIONAL INC. (US) | 2023-09-05 | — | — | US | claimed |
| US-11643398-B2 | Metallic salt containing anion having heterocyclic aromatic structure, method of preparing the metallic salt, and electrolyte and electrochemical device each including the metallic salt | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-05-09 | — | — | US | claimed |
| EP-3657590-B1 | METALLIC SALT CONTAINING ANION HAVING HETEROCYCLIC AROMATIC STRUCTURE, METHOD OF PREPARING THE SAME, AS WELL AS ELECTROLYTE AND ELECTROCHEMICAL DEVICE EACH INCLUDING THE METALLIC SALT | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-04-26 | — | — | EP | claimed |
| US-20090069581-A1 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-03-12 | — | — | US | claimed |
| WO-2008092939-A2 | PROCESS FOR THE PREPARATION OF OPTICALLY PURE OMEPRAZOLE VIA SALT FORMATION WITH A CHIRAL AMINE OR TREATMENT WITH AN ENTIOMER CONVERTING ENZYME AND CHROMATOGRAPHIC SEPARATION | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2008-08-07 | — | — | WO | claimed |
| WO-2008015217-A1 | SEPARATING CO2 FROM GAS MIXTURES | Universität Dortmund (DE) | 2008-02-07 | — | — | WO | claimed |
| US-6060617-A | REACTING AN ALKALI METAL HYDRIDE AND ALKALI METAL AMIDES WITH A SUBSTITUTED AMINE IN AN ETHER SOLVENT IN ABSENCE OF AN ELECTRON CARRIER TO PRODUCE AN ALKALI METAL AMIDE FREE OF ORGANIC CONTAMINANTS | FMC CORPORATION (US) | 2000-05-09 | — | — | US | claimed |
| EP-0843682-A1 | HIGH PURITY FORMULATIONS OF HIGHLY SUBSTITUTED LITHIUM AMIDE BASES | FMC CORPORATION (US) | 1998-05-27 | — | — | EP | claimed |
| US-5726308-A | High purity formulations of highly substituted lithium amide bases | FMC CORPORATION (US) | 1998-03-10 | — | — | US | claimed |
| WO-1997006173-A1 | HIGH PURITY FORMULATIONS OF HIGHLY SUBSTITUTED LITHIUM AMIDE BASES | FMC CORPORATION (US) | 1997-02-20 | — | — | WO | claimed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | claimed |
| US-4450114-A | Process for production of sulfuric acid semiesters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-05-22 | — | — | US | claimed |
| US-4351765-A | Process for the production of compounds having in the molecule at least one β-sulfatoethyl-sulfone group and at least one sulfonic acid group | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-09-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11643398-B2 | Metallic salt containing anion having heterocyclic aromatic structure, method of preparing the metallic salt, and electrolyte and electrochemical device each including the metallic salt | NAP1L1, AGTR1, AP2A1 | SIGMAR1 2649/4885ACP3 2342/4885CYP3A4 3889/4885 |
| US-20090069581-A1 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | CYP2B6, UGT1A6, CYP2A6 | SIGMAR1 901/4885ACP3 3352/4885CYP3A4 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.